In one case with a homozygous deletion of both CDKN2A and MTAP and one case with a homozygous CDKN2A deletion and heterozygous MTAP deletion, strong MTAP expression was seen in 10% of the tumor cells, whereas p16 was negative in both cases. This evidence concerns the gene CDKN2A and neoplasm.